Novel bacterial solutions for industrial pollution treatment
CellX Biosolutions AG
Incorporated
19.11.2024Headquarters
Zürich ETH-HönggerbergSupport
CellX Biosolutions creates innovative bacteria-based products for efficient and targeted treatment of industrial chemical pollution. Pollution caused by industrial chemical by-products is a major global issue. Conventional disposal is costly and harmful, while current biological methods struggle at scale. We are creating high-performance bacterial products to effectively degrade hazardous industrial chemicals, leveraging a novel microfluidic-based tool to capture in remote environments bacteria capable of pollutant degradation.
The co-founding team is composed by Dr. Estelle Clerc (CEO), Geoffrey Besnier (COO) and Dr. Fabienne Kurt (CSO). Pollution treatment represents a 30 billion USD market, expected to increase by 82% by 2027.
News
Venture Leaders Cleantech 2025: Captains Blog by Estelle Clerc and Murielle Schreck (venturelab.swiss)
Klimastiftung Schweiz unterstützt neun Startups mit über 1?Million Franken (startupticker.ch)
Das Finalisten-Feld des Swiss Technology Award 2025 (startupticker.ch)
CellX Biosolutions: The Venture Leader Cleantech developing bacterial solutions for industrial pollution (venturelab.swiss)
Venture Leaders Cleantech 2025 kick-off their Munich roadshow (venturelab.swiss)
Ten high-potential cleantech startups selected for Munich investor roadshow (startupticker.ch)
Swiss National Startup Team 2025: Ten high-potential Cleantech startups selected for Munich investor roadshow (venturelab.swiss)
Ten cleantech startups selected for Climate Collider in the US (startupticker.ch)
Life sciences, food and space start-ups sweep the prizes at the de Vigier award (startupticker.ch)
Ten finalists proceed to W. A de Vigier finale (startupticker.ch)
Eight Venture Kick alumni among finalists for De Vigier Award 2025 (venturekick.ch)
15 Startups advance to next stage of the W.A. de Vigier Award (startupticker.ch)
CellX secures CHF 1.7 million in pre-seed funding (startupticker.ch)
CellX Biosolutions secures CHF 1.7M in Pre-Seed Funding to tackle PFAS degradation (venturekick.ch)
3. Förderrunde von KlimUp: Vier Startups dabei (startupticker.ch)
CHF 40,000 for safe treatments for hemophilia, cholestasis and liver disease, and for a sustainable treatment of industrial chemical waste (venturekick.ch)